इसराइल -
हिब्रू -
Ministry of Health
נאורונטין 300 מג
pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.
इसराइल -
हिब्रू -
Ministry of Health
נאורונטין 400 מג
pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.
इसराइल -
हिब्रू -
Ministry of Health
נאורונטין 400 מג
pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.
इसराइल -
हिब्रू -
Ministry of Health
קסלג'אנז 5 מג
pfizer pharmaceuticals israel ltd - tofacitinib - טבליה - tofacitinib 5 mg - tofacitinib
इसराइल -
हिब्रू -
Ministry of Health
קסלג'אנז 5 מג
pfizer pharmaceuticals israel ltd - tofacitinib - טבליה - tofacitinib 5 mg - tofacitinib
इसराइल -
हिब्रू -
Ministry of Health
קסלג'אנז 10 מג
pfizer pharmaceuticals israel ltd - tofacitinib - טבליה - tofacitinib 10 mg - tofacitinib
इसराइल -
हिब्रू -
Ministry of Health
קסלג'אנז אקס אר 11 מג
pfizer pharmaceuticals israel ltd - tofacitinib as citrate - טבליות עם שחרור נרחב - tofacitinib as citrate 11 mg - tofacitinib
इसराइल -
हिब्रू -
Ministry of Health
וימפט 50 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
इसराइल -
हिब्रू -
Ministry of Health
וימפט 100 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.
इसराइल -
हिब्रू -
Ministry of Health
וימפט 150 מג
neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.